Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Tularik and Roche Bioscience collaborate on antiinflammatory drug discovery

July 25, 1997

Vyrex establishes proof of principle for CD-Tagging in human cells

July 22, 1997

Meridian launches TruJect autoinjector

July 21, 1997

SRI licenses drug formulation technology to Dura

July 21, 1997

ProLease drug formulation for the treatment of hormone-mediated disorders enters clinical trials

July 21, 1997

RiboGene and Trega Biosciences extend drug discovery collaboration

July 17, 1997

Update on CellPro's CEPRATE SC Stem Cell Concentration System

July 15, 1997

ArQule and Wyeth-Ayerst enter into drug discovery collaboration

July 15, 1997

ABS and Chinese Academy of Medical Science expand alliance

July 9, 1997

Oxford Molecular Group enters drug design agreement with Dainippon

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...